Human and rodent interferon-γ as a growth factor for Trypanosoma brucei
✍ Scribed by Moiz Bakhiet; Tomas Olsson; Jama Mhlanga; Philippe Büscher; Nils Lycke; Peter H. van der Meide; Krister Kristensson
- Book ID
- 102825251
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 606 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Human and rodent interferon-y as a growth factor for Trypanosoma brucei
An example for the bidirectional exchange of activating signals between a pathogen and immunocompetent cells in the host is presented. Trypanosoma brucei, which include subspecies that cause African sleeping sickness, secrete a molecule that triggers lymphocytes to produce interferon (1FN)-y. We now report that proliferation of 7: brucei is stimulated in axenic cultures by IFN-y. The growth-enhancing effect on the pathogen is inhibited by anti-IFN-y receptor (R) antibodies and does not occur after exposure to other cytokines, i.e. IFN-a, IFN-p and tumor necrosis factor (TNF)-a. While rodent-pathogenic 7: brucei strains are stimulated by rat IFN-y, human pathogenic strains are more potently stimulated by human IFN-y. Rat and human IFN-y can partially block each others effects. Mice with disrupted IFN-y genes have reduced parasitemia and prolonged survival, while the outcome is reversed in mice that lack the IFN-yR gene.
.
📜 SIMILAR VOLUMES
## Abstract Interferon‐γ (IFN‐γ) is a product of activated T‐lymphocytes, and tumor necrosis factor‐α (TNF‐α) is a product of both lymphocytes and macrophages. These cell types are often present at sites of tissue damage secondary to chronic infection or autoimmune disease. The purpose of this stud